BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36706482)

  • 1. Variability in opioid use disorder clinical presentations and treatment in the emergency department: A mixed-methods study.
    Faude S; Delgado MK; Perrone J; McFadden R; Xiong RA; O'Donnell N; Wood C; Solomon G; Lowenstein M
    Am J Emerg Med; 2023 Apr; 66():53-60. PubMed ID: 36706482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.
    Hawk KF; D'Onofrio G; Chawarski MC; O'Connor PG; Cowan E; Lyons MS; Richardson L; Rothman RE; Whiteside LK; Owens PH; Martel SH; Coupet E; Pantalon M; Curry L; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2020 May; 3(5):e204561. PubMed ID: 32391893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
    Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM
    JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.
    D'Onofrio G; Edelman EJ; Hawk KF; Chawarski MC; Pantalon MV; Owens PH; Martel SH; Rothman R; Saheed M; Schwartz RP; Cowan E; Richardson L; Salsitz E; Lyons MS; Freiermuth C; Wilder C; Whiteside L; Tsui JI; Klein JW; Coupet E; O'Connor PG; Matthews AG; Murphy SM; Huntley K; Fiellin DA
    JAMA Netw Open; 2023 Apr; 6(4):e235439. PubMed ID: 37017967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs.
    Sue KL; Chawarski M; Curry L; McNeil R; Coupet E; Schwartz RP; Wilder C; Tsui JI; Hawk KF; D'Onofrio G; O'Connor PG; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2023 May; 6(5):e2312718. PubMed ID: 37163263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency department interventions for opioid use disorder: A synthesis of emerging models.
    Thomas CP; Stewart MT; Tschampl C; Sennaar K; Schwartz D; Dey J
    J Subst Abuse Treat; 2022 Oct; 141():108837. PubMed ID: 35841743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
    Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
    J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizational factors associated with practitioners' support for treatment of opioid use disorder in the emergency department.
    Guerrero E; Ober AJ; Howard DL; Khachikian T; Kong Y; van Deen WK; Valdez A; Trotzky-Sirr R; Menchine M
    Addict Behav; 2020 Mar; 102():106197. PubMed ID: 31862684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METHADONE INITIATION IN THE EMERGENCY DEPARTMENT FOR OPIOID USE DISORDER: A CASE SERIES.
    Huo S; Heil J; Salzman MS; Carroll G; Haroz R
    J Emerg Med; 2023 Mar; 64(3):391-396. PubMed ID: 37019500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrupted Time Series of User-centered Clinical Decision Support Implementation for Emergency Department-initiated Buprenorphine for Opioid Use Disorder.
    Holland WC; Nath B; Li F; Maciejewski K; Paek H; Dziura J; Rajeevan H; Lu CC; Katsovich L; D'Onofrio G; Melnick ER
    Acad Emerg Med; 2020 Aug; 27(8):753-763. PubMed ID: 32352206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD).
    Khatri UG; Lee K; Lin T; D'Orazio JL; Patel MS; Shofer FS; Perrone J
    J Med Toxicol; 2022 Jul; 18(3):205-213. PubMed ID: 35415804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department.
    Wiercigroch D; Hoyeck P; Sheikh H; Hulme J
    BMC Emerg Med; 2021 Apr; 21(1):48. PubMed ID: 33858328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing System and Clinician Barriers to Emergency Department-initiated Buprenorphine: An Evaluation of Post-intervention Physician Outcomes.
    Mahal JJ; Bijur P; Sloma A; Starrels J; Lu T
    West J Emerg Med; 2024 May; 25(3):303-311. PubMed ID: 38801034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals.
    Patel E; Solomon K; Saleem H; Saloner B; Pugh T; Hulsey E; Leontsini E
    J Subst Abuse Treat; 2022 May; 136():108658. PubMed ID: 34774397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on and experiences of emergency department-initiated buprenorphine among clinical pharmacists: A multi-site qualitative study.
    Justen M; Edelman EJ; Chawarski M; Coupet E; Cowan E; Lyons M; Owens P; Martel S; Richardson L; Rothman R; Whiteside L; O'Connor PG; Zahn E; D'Onofrio G; Fiellin DA; Hawk KF
    J Subst Use Addict Treat; 2023 Dec; 155():209058. PubMed ID: 37149149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial of strengths-based case management to link emergency department patients to opioid use disorder treatment.
    Bogenschutz MP; McCormack R; Rapp R; Meyers-Ohki S; Mennenga SE; Regis A; Kolaric R; Glisker R; Greco PP
    J Subst Abuse Treat; 2022 Jul; 138():108745. PubMed ID: 35341615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences of patients at high risk of opioid overdose accessing emergency department and behavioral health interventions: a qualitative analysis in an urban emergency department.
    Collins AB; Baird J; Nimaja E; Ashenafi Y; Clark MA; Beaudoin FL
    BMC Health Serv Res; 2023 Apr; 23(1):370. PubMed ID: 37069593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
    Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
    J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
    Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
    Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.